[1]毕芳芳,史 敏,程微微,等.黄芪甲苷对缺血性卒中小鼠神经功能保护作用及机制研究[J].现代检验医学杂志,2023,38(01):89-93.[doi:10.3969/j.issn.1671-7414.2023.01.017]
 BI Fang-fang,SHI Min,CHENG Wei-wei,et al.Study on the Protective Effect and Mechanism of Astragaloside IV on Neurological Function in Mice with Ischemic Stroke[J].Journal of Modern Laboratory Medicine,2023,38(01):89-93.[doi:10.3969/j.issn.1671-7414.2023.01.017]
点击复制

黄芪甲苷对缺血性卒中小鼠神经功能保护作用及机制研究()
分享到:

《现代检验医学杂志》[ISSN:/CN:]

卷:
第38卷
期数:
2023年01期
页码:
89-93
栏目:
论著
出版日期:
2023-01-15

文章信息/Info

Title:
Study on the Protective Effect and Mechanism of Astragaloside IV on Neurological Function in Mice with Ischemic Stroke
文章编号:
1671-7414(2023)01-089-05
作者:
毕芳芳史 敏程微微张 露
(西安培华学院医学检验技术系,西安 710199)
Author(s):
BI Fang-fang SHI Min CHENG Wei-wei ZHANG Lu
(Department of Medical Laboratory Technology, Xi’an Peihua University, Xi’an 710199,China)
关键词:
黄芪甲苷缺血性卒中炎症氧化应激焦亡
分类号:
R-332
DOI:
10.3969/j.issn.1671-7414.2023.01.017
文献标志码:
A
摘要:
目的 探讨黄芪甲苷(astragaloside-IV, AST-IV)对缺血性卒中(ischemic stroke)模型鼠神经功能保护作用及机制研究。方法 选取改良线栓法制备大脑中动脉梗死(middle cerebral artery occlusion,MCAO)小鼠模型,小鼠分成四组,每组8 只,分别为假手术组(Sham)、药物对照组(AST-IV)、MCAO 组和治疗组(AST-IV+MCAO);采用改良神经功能损伤评分(modified neurological severity score,mNSS)实验和转棒(Rotarod)实验综合评价ASTIV的神经保护功能;采用ELISA 法检测AST-IV 对MCAO 脑组织核转录因子(NF-KB)、Toll 样受体4(TLR-4)、肿瘤坏死因子α(TNF-α)、胶质纤维酸性蛋白(glial fibrillary acidic protein ,GFAP)、血红素氧合酶-1(HO-1) 以及半胱天冬酶-1(caspase-1) 表达水平的影响;采用比色法检测AST-IV 对MCAO 脑组织丙二醛(MDA)、超氧化物歧化酶(SOD)、谷胱甘肽(GSH) 和活性氧(ROS)表达水平的影响。结果 MCAO组的mNSS评分(54.06±8.52)、脑组织ROS(54.06±8.52AFU)、MDA(2.40±0.33 nmol/mg),NF-κB(304.94±39.93pg/mg),TLR4(225.60±37.51pg/mg),TNF-α(80.14±11.06pg/mg),GFAP(181.24±19.88pg/mg)和caspase-1(1.76±0.20)表达均显著高于Sham 组(0.75±0.89,19.85±2.45AFU,1.43±0.29 nmol/mg,131.03±29.45 pg/mg,102.74±19.18 pg/mg,32.04±10.30 pg/mg,63.14±14.48pg/mg,1.00±0.09),差异具有统计学意义(F=38.572 ~ 184.478,均P<0.001);MCAO 组在Rotarod 上的停留时间(74.63±18.73s),脑组织SOD(2.88±0.49unin/mg),GSH(3.49±0.64nmol/mg)和HO-1(105.93±24.45pg/ml)表达均显著低于Sham 组(186.50±48.10s,5.58±0.71unit/mg,6.32±0.82 pg/ml,203.11±28.65pg/ml),差异具有统计学意义(F=37.586 ~ 78.889,均P<0.001);AST-IV+MCAO组的mNSS评分(3.88±1.36)、脑组织ROS(24.64±14.26AFU),MDA(2.00±0.21nmol/mg),NF-κB(212.03±38.63 pg/mg),TLR-4(134.81±25.60 pg/mg),TNF-α(53.61±12.49pg/mg),GFAP(101.00±15.04 pg/mg)和caspase-1(1.46±0.15)表达均显著低于MCAO 组,差异具有统计学意义(F=4.639 ~ 82.890, 均P<0.05);AST-IV+MCAO 组在Rotarod 上的停留时间(160.75±33.33s), 脑组织SOD(4.51±0.51unit/mg),GSH(5.30±0.73nmol/mg)和HO-1(179.96±20.97pg/ml)均显著高于MCAO 组,差异具有统计学意义(F=27.681 ~ 42.364,均P<0.001)。结论 AST-IV 的脑保护作用可能与其抗炎、抗氧化应激、抑制焦亡进程有关。
Abstract:
Objective To investigate the protective effect and mechanism of astragaloside IV(AST-IV)in a mouse model of ischemic stroke. Methods The middle cerebral artery occlusion(MCAO) mouse model was established by the modified suture method. The mice were divided into four groups with 8 mice in each group, namely the Sham group, the AST-IV group, the MCAO group and the AST-IV+MCAO group. The neuroprotective function of AST-IV was comprehensively evaluated by modified neurological severity score (mNSS) test and Rotarod test. ELISA was used to detect the effect of AST-IV on the expression levels of nuclear factor kappa-B (NF-κB), Toll like receptor 4(TLR-4), Tumor necrosis factor-α(TNF-α), glial fibrillary acidic protein (GFAP), heme oxygenase-1 (HO-1) and caspase-1in MCAO brain tissue. Colorimetry was used to detect the effect of AST-IV on the expression levels of malondialdehyde (MDA), Superoxide dismutase(SOD), glutathione (GSH) and reactive oxygen species(ROS) in MCAO brain tissue. Results The mNSS score(54.06±8.52) in MCAO group, the expression of ROS(54.06±8.52 AFU), MDA(2.40±0.33 nmol/mg), NF-κB(304.94±39.93pg/mg),TLR-4(225.60±37.51pg/mg), TNF-α(80.14±11.06pg/mg), GFAP (181.24±19.88pg/mg)and caspase-1(1.76±0.20) in brain tissue were significantly higher than those in the Sham group(0.75±0.89,19.85±2.45AFU,1.43±0.29 nmol/mg, 131.03±29.45 pg/mg,102.74±19.18 pg/mg,32.04±10.30 pg/mg,63.14±14.48 pg/mg,1.00±0.09), and the differences were statistically significant (F=8.572 ~ 184.478, all P<0.001). The MCAO group had a longer residence time (74.63±18.73s) on Rotarod, the expression of SOD(2.88±0.49unin/mg), GSH(3.49±0.64nmol/mg) and HO-1(105.93±24.45pg/ml)in brain tissue were significantly lower than those in the Sham group(186.50±48.10s,5.58±0.71unit/mg,6.32±0.82 pg/ml, 203.11±28.65pg/ml), and the differences were statistically significant (F =37.586~78.889, all P<0.001). The mNSS score (3.88±1.36) in the AST-IV+MCAO group, the expression of ROS(24.64±14.26AFU), MDA(2.00±0.21nmol/mg), NF-κB(212.03±38.63 pg/mg), TLR-4(134.81±25.60 pg/mg), TNF -α(53.61±12.49 pg/mg), GFAP(101.00±15.04 pg/mg) and caspase-1 (1.46±0.15)in the brain tissue were significantly lower than MCAO group, and the differences were statistically significant (F=4.639 ~ 82.890,all P<0.05). AST-IV+MCAO group stay on Rotarod time(160.75±33.33s), the expression of SOD(4.51±0.51unit/mg), GSH(5.30±0.73nmol/mg)and HO-1(179.96±20.97pg/ml)were significantly higher than those in the MCAO group, and the differences were statistically significant (F=27.681 ~ 42.364, all P<0.001). Conclusion The brain protective effect of AST-IV may be related to its anti inflammation, anti-oxidative stress, and inhibition of coke death process.

参考文献/References:

[1] 郭洁, 池水侠. 急性缺血性脑卒中患者血清miR-181C-5p, miR-340-5p和miRNA146a水平表达检测的诊断价值研究[J]. 现代检验医学杂志, 2021, 36(5):43-45.
GUO Jie, CHI Shuixia. Diagnostic value of miRNA-181c-5p, miRNA-340-5p and miRNA146a levels in patients with acute ischemic stroke [J]. Journal of Modern Laboratory Medicine, 2021, 36(5): 43-45.
[2] 韩晶晶, 杨帆, 周旭强, 等. 急性缺血性脑卒中患者血清小而密低密度脂蛋白胆固醇水平与心脑血管狭窄程度的相关性研究[J]. 现代检验医学杂志, 2020,35(3): 42-46.
HAN Jingjing, YANG Fan, ZHOU Xuqiang, et al. Study on the correlation between low density lipoprotein(LDL)cholesterol level and the severity of cardiovascular and cerebrovascular stenosis in patients with acute ischemic stroke [J]. Journal of Modern Laboratory Medicine, 2020, 35(3): 42-46.
[3] WANG Shuxia, MOU Jianguo, CUI Lansong, et al.Astragaloside IV inhibits cell proliferation of colorectal cancer cell lines through down-regulation of B7-H3[J].Biomedicine & Pharmacotherapy, 2018, 102: 1037-1044.
[4] BI Fangfang , ZHANG Yiyong , LIU Wenbo, et al.Sinomenine activation of Nrf2 signaling prevents inflammation and cerebral injury in a mouse model of ischemic stroke[J]. Experimental and Therapeutic Medicine, 2021, 21(6): 647.
[5] TOB?N-VELASCO J C, V?ZQUEZ-VICTORIO G, MAC?AS-SILVA M, et al. RETRACTED:S-allyl cysteine protects against 6-hydroxydopamine-induced neurotoxicity in the rat striatum:involvement of Nrf2 transcription factor activation and modulation of signaling kinase cascades[J]. Free Radical Biology & Medicine, 2012, 53(5): 1024-1040.
[6] KIASALARI Z, ROGHANI M, KHALILI M, et al.Antiepileptogenic effect of curcumin on kainateinduced model of temporal lobe epilepsy[J].Pharmaceutical Biology, 2013, 51(12): 1572-1578.
[7] SEDLAK J, LINDSAY R H. Estimation of total,protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent[J]. Analytical Biochemistry, 1968, 25(1): 192-205.
[8] VIRANI S S, ALONSO A, BENJAMIN E J, et al.Heart disease and stroke statistics-2020 update: a report from the American Heart Association[J]. Circulation,2020, 141(9): e139-e596.
[9] KHOSHNAM S E, WINLOW W, FARBOOD Y, et al.Emerging roles of microRNAs in ischemic stroke: as possible therapeutic agents[J]. Journal of Stroke, 2017,19(2): 166-187.
[10] MOHIDEEN K, SUDHAKAR U, BALAKRISHNAN T, et al. Malondialdehyde, an oxidative stress marker in oral squamous cell Carcinoma-A systematic review and meta-analysis[J]. Current Issues in Molecular Biology,2021, 43(2): 1019-1035.
[11] DU Jin, YIN Guobing, HU Yida, et al. Coicis semen protects against focal cerebral ischemia-reperfusion injury by inhibiting oxidative stress and promoting angiogenesis via the TGFβ/ALK1/Smad1/5 signaling pathway[J]. Aging, 2020, 13(1): 877-893.
[12] XIAO Lan, DAI Ziwei, TANG Wenjing, et al.Astragaloside IV alleviates cerebral ischemiareperfusion injury through NLRP3 inflammasomemediated pyroptosis inhibition via activating Nrf2[J].Oxidative Medicine and Cellular Longevity,2021, 2021:9925561.
[13] LI Wenxing, QI Fei, LIU Jiaqian, et al. Different impairment of immune and inflammation functions in short and long-term after ischemic stroke[J]. American Journal of Translational Research, 2017, 9(2): 736-745.
[14] GAO Bo, WU Yu, YANG Yuanjian, et al. Sinomenine exerts anticonvulsant profile and neuroprotective activity in pentylenetetrazole kindled rats: involvement of inhibition of NLRP1 inflammasome[J]. Journal of Neuroinflammation, 2018, 15(1): 152.
[15] ZHANG Bei, ZHANG Haixiong, SHI Shaoting, et al. Interleukin-11 treatment protected against cerebral ischemia/reperfusion injury[J]. Biomedicine & Pharmacotherapy, 2019, 115: 108816.
[16] BERGSBAKEN T, FINK S L, COOKSON B T. Pyroptosis:host cell death and inflammation[J]. Nature Reviews Microbiology, 2009, 7(2): 99-109.

相似文献/References:

[1]伏彩霞a,马宝山,鲁晓波b.缺血性卒中患者血清SOD,NO,MDA水平动态变化与焦虑症发生的相关性[J].现代检验医学杂志,2018,33(06):46.[doi:10.3969/j.issn.1671-7414.2018.06.012]
 FU Cai-xiaa,MA Bao-shan,LU Xiao-bob.Correlation of Dynamic Changes of Serum SOD,NO and MDA in Patients with Ischemic Stroke and Anxiety[J].Journal of Modern Laboratory Medicine,2018,33(01):46.[doi:10.3969/j.issn.1671-7414.2018.06.012]
[2]樊春荔,何燕娟.缺血性脑卒中和短暂性脑缺血发作患者血清miR-23b-3p 水平变化的比较研究[J].现代检验医学杂志,2020,35(05):51.[doi:10.3969/j.issn.1671-7414.2020.05.013]
 FAN Chun-li,HE Yan-juan.Altered Levels of Serum miR-23b-3p in Patients with Ischemic Stroke and Transient Ischemic Attack[J].Journal of Modern Laboratory Medicine,2020,35(01):51.[doi:10.3969/j.issn.1671-7414.2020.05.013]

备注/Memo

备注/Memo:
基金项目:陕西省教育厅科研计划项目(21JK0820),陕西省自然科学基础研究计划(2022JQ-876,2022JM-558)。
作者简介:毕芳芳(1991-),女,硕士研究生,讲师,研究方向:神经炎症,E-mail: 2014zora@sina.com。
通讯作者:张露(1987-),男,硕士研究生,主管技师,E-mail:459688381@qq.com。
更新日期/Last Update: 2023-01-15